Spots Global Cancer Trial Database for The Metformin Active Surveillance Trial (MAST) Study
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: The Metformin Active Surveillance Trial (MAST) Study
Official Title: A Randomized, Double-Blind, Placebo-Controlled Trial of Metformin in Reducing Progression Among Men on Expectant Management for Low Risk Prostate Cancer: The MAST (Metformin Active Surveillance Trial) Study
Study ID: NCT01864096
Conditions
Study Description
Brief Summary: This study aims to see if metformin can delay the time to progression in men with low risk prostate cancer when compared to a placebo.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: No
Locations
Manitoba Cancer Care Centre, Winnipeg, Manitoba, Canada
CDHA - Victoria Site, Halifax, Nova Scotia, Canada
McMaster Institute of Urology-St .Joseph's Healthcare, Hamilton, Ontario, Canada
Centre for Appled Urologic Research, Kingston General Hospital, Kingston, Ontario, Canada
London Health Sciences Centre-Victoria Hospital, London, Ontario, Canada
Ottawa Hospital Research Institute (The Ottawa Hospital), Ottawa, Ontario, Canada
Sunnybrook Research Institute, Toronto, Ontario, Canada
Princess Margaret Cancer Centre, Toronto, Ontario, Canada
Centre L'Hopitalie de l'Universite de Montreal, Montreal, Quebec, Canada
MUHC - Montreal General Hospital, Montreal, Quebec, Canada
Centre de Recherche du CHUS, Sherbrooke, Quebec, Canada
Alberta Urology Institute, Edmonton, , Canada
Contact Details
Name: Neil Fleshner, MD, MPH, FRCSC
Affiliation: University Health Network: Department of Surgical Oncology (Urology)
Role: PRINCIPAL_INVESTIGATOR
Name: Anthony Joshua, MD
Affiliation: University Health Network: Department of Surgical Oncology (Urology)
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
